Region Area

Lawyers

Search rankings
  • search
Christopher Moore
Christopher Moore
Christopher Moore’s practice focuses on international arbitration and litigation. He is the co-head of the firm’s global international arbitration group. Chris has represented multinational corporations in complex international commercial arbitrations across a range of industries seated in the world’s most frequently selected arbitral seats and before tribunals formed under the rules of the leading institutional and ad hoc arbitration regimes, including the International Chamber of Commerce (ICC), London Court of International Arbitration (LCIA), Stockholm Chamber of Commerce (SCC), Singapore International Arbitration Centre (SIAC), Hong Kong International Arbitration Centre (HKIAC), and UNCITRAL, and in litigation matters before state and federal courts throughout the United States. Chris also has extensive experience acting as counsel in matters involving foreign states both in investor-state disputes under the rules of the International Centre for the Settlement of Investment Disputes (ICSID) and in international litigation proceedings, including litigation involving the immunity of foreign states and their agencies under the U.S. Foreign Sovereign Immunities Act and public international law.
Irena Royzman
Irena Royzman, Ph.D., head of the firm's Life Sciences practice, represents pharmaceutical, biotech and medical device companies in patent litigation, advising both plaintiffs and defendants in every stage of the litigation process from pre-suit investigation through trials and appeals. She litigates a wide range of subject matters including small molecule drugs, antibodies, manufacturing processes, point-of-care diagnostics, gene-editing technology, gene therapies and drug-eluting coatings. She has particular depth of experience in litigation under the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act (BPCIA). In addition, she represents clients in inter partes reviews and high-stakes license disputes. Irena also provides strategic counseling in the area of biologics and pharmaceuticals and advises clients on contractual and licensing issues.